Cannabis is the most commonly used substance among people with ADHD.
Many individuals report perceived benefits, particularly in:
- emotional regulation,
- irritability,
- evening restlessness,
- sleep initiation,
- and offsetting stimulant rebound.
At the same time, cannabis is not benign and is certainly not a treatment for ADHD. In a small proportion of patients, and usually limited to short periods following use, cannabis can cause:
- transient anxiety or paranoia,
- short-term memory difficulties,
- reduced clarity of thought,
- or worsening emotional reactivity.
The long-standing concept of an “amotivational syndrome” has very limited empirical support and is increasingly viewed as an oversimplification that fails to account for underlying ADHD, sleep disturbance, or emotional dysregulation. Reduced motivation is therefore better understood in context rather than assumed to be a direct effect of cannabis itself.
The clinical reality is nuanced. Cannabis is neither panacea nor poison. Its effects vary widely between individuals, doses, strains, and contexts. Importantly, most harms described in the literature are extrapolated from schizophrenia and adolescent neurotoxicity studies, often without accounting for ADHD, sleep disturbance, or emotional dysregulation as confounding factors.
In many patients, I actively encourage consideration of medicinal cannabis rather than unregulated use. Medical cannabis is carefully regulated, titrated, and prescribed, allowing greater confidence in dose, content, and consistency, and enabling clearer monitoring of benefits and adverse effects.
My approach is balanced and non-judgemental. My role is not to moralise or punish cannabis use, but to help patients understand why they are using it, what it may be helping with, what it may be worsening, and how this often changes once ADHD is properly treated.